James C. Costello, Ph.D.
Affiliations: | 2009 | Informatics | Indiana University, Bloomington, Bloomington, IN, United States |
Area:
Bioinformatics Biology, Information ScienceGoogle:
"James Costello"Parents
Sign in to add mentorMehmet M. Dalkilic | grad student | 2009 | Indiana University | |
(Data integration and applications of functional gene networks in Drosophila melanogaster.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sobral LM, Hicks HM, Parrish JK, et al. (2020) KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1-driven and independent disease-promoting gene expression in fusion-positive Rhabdomyosarcoma. Molecular Oncology |
Zhou H, Blevins MA, Hsu JY, et al. (2020) A SIX1/EYA2 small molecule inhibitor disrupts EMT and metastasis. Cancer Research |
Stern JL, Hibshman G, Hu K, et al. (2020) Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers. Molecular Cancer Research : McR |
Goodspeed AE, Jean A, Costello JC. (2020) Abstract B08: MSH2 downregulation induces chemoresistance in bladder cancer Clinical Cancer Research. 26 |
Washino S, Rider LC, Romero L, et al. (2019) Loss of MAP3K7 sensitizes prostate cancer cells to CDK1/2 inhibition and DNA damage by disrupting homologous recombination. Molecular Cancer Research : McR |
Oliphant MUJ, Vincent MY, Galbraith MD, et al. (2019) Six2 mediates late-stage metastasis via direct regulation of Sox2 and induction of a cancer stem cell program. Cancer Research |
Jones RT, Zuiverloon TC, Vekony H, et al. (2019) Abstract 2107: Integrative molecular and functional genomic analysis of chemotherapy resistant bladder cancer cell lines identifies novel mediators of therapeutic response Cancer Research |
Laajala TD, Gerke T, Tyekucheva S, et al. (2019) Modeling genetic heterogeneity of drug response and resistance in cancer Current Opinion in Systems Biology. 17: 8-14 |
Morgan MJ, Fitzwalter BE, Owens CR, et al. (2018) Metastatic cells are preferentially vulnerable to lysosomal inhibition. Proceedings of the National Academy of Sciences of the United States of America |
Oliphant MU, Pandey A, Johnson K, et al. (2018) Abstract 5001: Identification of a Six2/Sox2/Nanog stem cell axis that promotes breast cancer metastatic colonization Cancer Research. 78: 5001-5001 |